FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo
- 1 October 2000
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 7 (10) , 805-812
- https://doi.org/10.1016/s1074-5521(00)00028-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- HMGI(Y) and HMGI-C DysregulationAdvances in Anatomic Pathology, 1999
- Alu Repeats and Human DiseaseMolecular Genetics and Metabolism, 1999
- FR-66979 Covalently Cross-Links the Binding Domain of the High-Mobility Group I/Y Proteins to DNAJournal of the American Chemical Society, 1998
- Analysis of Chromatin Structure byin VivoFormaldehyde Cross-LinkingMethods, 1997
- High Mobility Group Protein I(Y) Is Required for Function and for c-Rel Binding to CD28 Response Elements within the GM-CSF and IL-2 PromotersImmunity, 1996
- Mitomycin C: small, fast and deadly (but very selective)Chemistry & Biology, 1995
- Covalent Structure of the DNA-DNA Interstrand Cross-Link Formed by Reductively Activated FR66979 in Synthetic DNA DuplexesJournal of the American Chemical Society, 1994
- Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elementsCell, 1993
- The High Mobility Group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β geneCell, 1992
- Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.The Japanese Journal of Pharmacology, 1989